A novel tumor-vaccine cell therapy using bone marrow-derived dendritic cell type 1 and antigen-specific T h 1 cells

By Sato M.   Chamoto K.   Nishimura T.  

International Immunology, Vol. 15, Iss. 7, 2003-07 ,pp. : 837-843

Oxford University Press

Access to resources Recommend Favorite

IL-13 from T h 2-type cells suppresses induction of antigen-specific T h 1 immunity in a T-cell lymphoma

By Deepak Praveen   Kumar Sanjay   Kishore Dhiraj   Acharya Arbind  

International Immunology, Vol. 22, Iss. 1, 2010-01 ,pp. : 53-63

Oxford University Press

Access to resources Recommend Favorite

Requirement of tumor-associated antigen-specific CD4 + T cells for an efficient dendritic cell vaccine in antitumor immunotherapy

By Simon Thomas   Fonteneau Jean-François   Grégoire Marc  

Immunotherapy, Vol. 5, Iss. 6, 2013-06 ,pp. : 565-567

Future Medicine

Access to resources Recommend Favorite

Chimeric antigen receptor-redirected T cells display multifunctional capacity and enhanced tumor-specific cytokine secretion upon secondary ligation of chimeric receptor

By Henderson Melissa A   Yong Carmen SM   Duong Connie PM   Davenport Alexander J   John Liza B   Devaud Christel   Neeson Paul   Westwood Jennifer A   Darcy Phillip K   Kershaw Michael H  

Immunotherapy, Vol. 5, Iss. 6, 2013-06 ,pp. : 577-590

Future Medicine

Access to resources Recommend Favorite

Irradiated CIITA-positive mammary adenocarcinoma cells act as a potent anti-tumor-preventive vaccine by inducing tumor-specific CD4 + T cell priming and CD8 + T cell effector functions

By Mortara Lorenzo   Frangione Valeria   Castellani Patrizia   De Lerma Barbaro Andrea   Accolla Roberto S.  

International Immunology, Vol. 21, Iss. 6, 2009-06 ,pp. : 655-665

Oxford University Press

Access to resources Recommend Favorite